Penumbra, Inc Cash and Cash Equivalents, Period Increase (Decrease)
Penumbra, Inc (PEN) reported Cash and Cash Equivalents, Period Increase (Decrease) of $43.73 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-11-07
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $34.32M.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$18.34M, a 365.87% decline year-over-year.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $27.76M, a 1180.26% increase year-over-year.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $20.11M.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for fiscal 2018 was $17.21M, a 53.98% decline from fiscal 2017.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for fiscal 2017 was $37.40M.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$6.31M, a 138.82% decline from fiscal 2015.
- Penumbra, Inc cash and cash equivalents, period increase (decrease) for fiscal 2015 was $16.26M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $34.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $15.97M derived: sum of 2 quarters · filed 2019-11-07 | $43.73M 10-Q · filed 2019-11-07 | $63.84M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$18.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $9.41M 10-Q · filed 2019-08-06 | $29.52M derived: sum of 3 quarters · filed 2019-08-06 | $17.56M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $27.76M 10-Q · filed 2019-05-07 | $47.86M derived: sum of 2 quarters · filed 2019-05-07 | $35.90M derived: sum of 3 quarters · filed 2019-11-07 | $42.80M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $20.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.14M derived: sum of 2 quarters · filed 2019-11-07 | $15.04M derived: sum of 3 quarters · filed 2019-11-07 | $17.21M 10-K · filed 2019-02-26 |
| 2018-09-30 | -$11.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$5.06M derived: sum of 2 quarters · filed 2019-11-07 | -$2.90M 10-Q · filed 2019-11-07 | -$17.88M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $9.07M 10-Q · filed 2019-08-06 | -$5.92M derived: sum of 3 quarters · filed 2019-08-06 | -$16.87M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $2.17M 10-Q · filed 2019-05-07 | -$12.82M derived: sum of 2 quarters · filed 2019-05-07 | -$23.77M derived: sum of 3 quarters · filed 2019-05-07 | -$56.58M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | -$14.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$25.94M derived: sum of 2 quarters · filed 2019-02-26 | -$58.75M derived: sum of 3 quarters · filed 2019-02-26 | $37.40M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$10.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$43.76M derived: sum of 2 quarters · filed 2017-11-07 | $52.38M 10-Q · filed 2017-11-07 | $49.77M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$32.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $63.34M 10-Q · filed 2017-08-08 | $60.72M derived: sum of 3 quarters · filed 2019-02-26 | $62.66M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $96.15M 10-Q · filed 2017-05-09 | $93.53M derived: sum of 2 quarters · filed 2019-02-26 | $95.47M derived: sum of 3 quarters · filed 2019-02-26 | $91.78M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$678.00K derived: sum of 2 quarters · filed 2019-02-26 | -$4.37M derived: sum of 3 quarters · filed 2019-02-26 | -$6.31M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.75M derived: sum of 2 quarters · filed 2017-11-07 | -$3.69M 10-Q · filed 2017-11-07 | -$143.24M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$3.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$5.63M 10-Q · filed 2017-08-08 | -$145.18M derived: sum of 3 quarters · filed 2018-02-27 | -$22.85M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$1.94M 10-Q · filed 2017-05-09 | -$141.49M derived: sum of 2 quarters · filed 2018-02-27 | -$19.16M derived: sum of 3 quarters · filed 2018-02-27 | $9.47M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$139.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$17.22M derived: sum of 2 quarters · filed 2018-02-27 | $11.41M derived: sum of 3 quarters · filed 2018-02-27 | $16.26M 10-K · filed 2018-02-27 |
| 2015-09-30 | $122.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $150.97M derived: sum of 2 quarters · filed 2016-11-03 | $155.81M 10-Q · filed 2016-11-03 | $150.91M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $28.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $33.47M 10-Q · filed 2016-08-09 | $28.58M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $4.84M 10-Q · filed 2016-05-09 | -$56.00K derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$841.00K 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $4.06M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | -$3.30M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |